Pfizer Stock Has 29% Upside, Says a New Bull
Guggenheim analysts initiated coverage of drug firm Pfizer at Buy with a $36 price target. Shares have lagged behind the market in recent years.
Source: marketwatch.com
📰 Courtesy Pfizer News
Courtesy Pfizer News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Courtesy Pfizer. Real-time updates on events, politics, business and more.
Pfizer Stock Dives. Its New Guidance Is Disappointing the Market.
Pfizer stock was falling early Wednesday after the pharmaceutical company revised its guidance for 2024.
Adam Clark Courtesy Pfizer Article Normal Healthcare Life Sciences Financial Performance Earnings Projections
Source: marketwatch.com
Pfizer Stock Falls to 10-Year Low on Guidance Slash. Why Wall Street Is Disappointed.
Pfizer stock was trading at a 10-year low on Wednesday after the pharmaceutical company revised its 2024 guidance. Its new earnings and revenue projections...
Source: marketwatch.com
Pfizer's Weight Loss Drug Won't Enter a Phase 3 Trial. The Stock Drops.
'We believe an improved once-daily formulation of danuglipron could play an important role in the obesity treatment paradigm,' Pfizer says
Source: marketwatch.com
Data on Pfizer's New Weight Loss Pill Is Coming. Why it's Crucial for the Stock.
Pfizer needs some of the obesity drug enthusiasm that's lifted Eli Lilly and Novo Nordisk stock.
Source: marketwatch.com
Pfizer Stock Drops After Guidance Cut. Its Post-Covid Place Is Unsure.
The U.S. government will return treatments of the company's Paxlovid drug as coronavirus vaccination rates fall.
Source: marketwatch.com
Pfizer Taps Samsung Biologics in $900 Million Manufacturing Deal
Pfizer will look to the biotech arm of Samsung to manufacture biosimilar products ranging from oncology to immunotherapy.
Source: marketwatch.com